Founded in 2015, RYSE is a diverse team with a strong investment management background combined with experience across venture capital, entrepreneurship, healthcare, research, operations, and technology.
Shabir Chowdhary, Managing Partner
Shabir has a track record of building companies and supporting company founders across multiple sectors. The majority of his career has been spent building and managing asset management businesses across Europe. He was successful in developing and executing fundraising and marketing strategies that enabled collaboration with private groups and public bodies and substantial investment from a variety of highly reputable foundations, endowments, charities, pension funds, insurance companies as well as fund of funds and bank investors. Asset management businesses Shabir has been involved with have raised in excess of $4.5bn in aggregate and several sold to strategic buyers.
Dr John Lee Allen, Managing Partner
John is a venture capital investment professional with a track record across healthcare, as a physician, research scientist, and technology entrepreneur. With an engineering and biology background, his focus spans healthtech and biotech. John has published widely and leads a global team of Venture Analysts as a Principal at GoingVC. He developed an implantable biotech device as a neuroscience PhD student at Oxford University, leading him down the path as a serial tech entrepreneur and angel investor. He was a partner at Specsavers supporting their global expansion into hearing care and is a national NHS Clinical Entrepreneur Fellow.
Eric Kostegan, Impact Investing Lead
Eric is an impact investing and venture philanthropy leader with a 25-year track record building and leading innovative healthcare programmes and ventures globally. He has raised over $600m in capital with specific expertise working with organisations in healthcare including Mount Sinai Health System, Jefferson Health, and Mass General Brigham (Harvard) Integrated Health Care System.
Vivien de Tusch-Lec, Venture Advisor
Vivien is an investor, entrepreneur, and has had 3 exits as a start-up founder (Infinancials, Bubele, Martialfunk). She ran the Tech, Media, Telecom unit for B2B Marketplace Gerson Lehman Group - and has been supporting the Investment Committee at RYSE. In 2018, she was a co-investor during the first investment programme with DigitalHealth.London and MedCity, in Skin Analytics and LiveSmart, and now manages a portfolio of technology investments.
Vivien loves operating in start-ups, is an advisor to Loyal VC, a former journalist, and non-exec director at Techspert.io. She holds a Masters degree from the University of Cambridge and an MBA from INSEAD.LinkedIn
Rodrigo Mallo Leiva, Venture Advisor
Rodrigo is an investor and Partner at Luminous Ventures. Formerly a Partner at SOSV, he has invested in over 45 companies at Seed and Series A, and is an active investor in digital healthcare. He is a mentor for The Founder Institute, Techstars, and is an Ambassador for the MIT Technology Review in Europe. He founded four LatAm technology companies in the food, gaming, and digital advertising industries.
Rodrigo is a Kauffman Fellow, became an angel investor after selling gaming company (TheFanLeague), and holds executive qualifications in venture capital from UC Berkeley.LinkedIn
Dr Benjamin Maddison, Venture Advisor
Ben’s passion is creating tomorrow through scalable sustainable innovation and business transformation. His background in commercial innovation, strategy, change and project management uniquely positions him with a blend of valuable skills, knowledge and broad sector experience. This is with some of the largest global companies including Costa Coffee, owned by The Coca-Cola Company, and leading consumer healthcare brands at Unilever. His 18+ years experience spans several industries including healthcare, pharmaceutical, public sector and consumer goods.
Ben holds a PhD from Imperial College London, specialising in molecular neurochemistry, an undergraduate degree in Biochemistry, and has a proven track record on launching disruptive innovations in global markets.LinkedIn
Rebecca Sweetman, Venture Advisor
Becca supports CEOs and Executive teams to maximise their potential and is passionate about digital healthcare. Combining her experience in executive coaching, strategy at McKinsey & Company, and operational leadership in start-ups (Kano, MOO, Babylon Health) she is uniquely positioned to provide both high level support and get into the practical details of what it takes to succeed.
Becca holds a degree in Economics and Management from the University of Oxford and works with impact driven companies, particularly in healthcare, as an Executive and Team Coach, Advisor, or Non-Executive Director.LinkedIn
Dr Vishaal Virani, Venture Advisor
Vishaal is a medical doctor, strategy consultant, and co-founder of Doctorpreneurs - the world’s largest community of medical innovators – with skills across digital health, private equity due diligence and corporate strategy. He has worked on the leading global consumer healthcare brands at RB, business development at digital healthcare company Ada Health, and currently working on health partnerships at YouTube.
Vishaal holds degrees in Medicine and in International Health from University College London. He is Governor of the Royal Free NHS Trust, Mentor at DigitalHealth.London, and guest lecturer at London Business School.LinkedIn
Odhran O'Donoghue, Venture Analyst
Odhran is a MD/PhD candidate at Oxford University. He is president of the Oxford Artificial Intelligence Society, which is the largest student AI society in Europe. He previously worked on the application of AI for detecting biases in recruitment systems and satellite systems, and he was the UK's youngest NHS Clinical Entrepreneur Fellow.
Odhran is also an Included VC fellow and co-founder of SkillsTree, an education technology startup to help individuals find skills that will improve their employment prospects locally. SkillsTree won the UK finals of the 2018 United Nations International Hult Prize and was funded by the UK Department for Education.LinkedIn
Bhumi Shah, Venture Analyst
Bhumi is a MD candidate at Cambridge University with an interest in innovation, policy, and digital healthcare start-ups with the potential to have a positive impact on healthcare globally. She is co-founder of The Medicine Access Project, Cambridge Nutritank society, and business development analyst at digital healthcare start-up SolveMed Group.
Bhumi is section council representative at the Royal Society of Medicine, Trustee of the Pelvic Radiation Disease Association, and has held innovation and research roles with Columbia University, Harvard University, Imperial College London, and the National Institute for Health Research (NIHR).LinkedIn
Chris Turner, Entrepreneur-in-Residence
Chris is a serial entrepreneur and the founder of Dimec, the UK based digital healthcare start-up that was acquired by Co-op Health in 2018. Dimec, now Co-op Health, facilitates the ordering of repeat prescriptions by linking patients directly with their GP surgery. It was the very first GP and pharmacy integrated service, giving patients the choice of having their prescriptions delivered or to collect from any high street pharmacy in England.
Chris holds a first class Master in Pharmacy degree, is an NHS qualified pharmacist, and an NHS Clinical Entrepreneur Fellow.LinkedIn
Dr Carina Tyrrell, Entrepreneur-in-Residence
Carina is a British-Swiss public health physician, ex-founder, and research fellow at Cambridge University. She has worked with the NHS, Clinical Commissioning Groups, local and national government, and the World Health Organization, publishing international policy and research. With government agencies and the Cambridge Judge Business School, she is working in operations and technology management, and in improving healthcare delivery. She has been identifying COVID-19 vaccine and therapeutic trials, publishing work with Oxford University.
Carina holds a degree in Medicine and Masters of Public Health from the University of Cambridge. Carina has appeared on BBC News, Sky News, Radio 4, and has been featured in The Times, Daily Telegraph, and Business Insider.LinkedIn Google Scholar
Dr Annalisa Jenkins, Healthcare advisor
Annalisa Chairs our Advisory Board and has a 25-year track record in building and leading teams from scientific research through clinical development, regulatory approval and into healthcare systems globally. She is Chair of The Conduit Connect, a London-based club driving positive social change, which provides Credit Suisse clients access to impact investment opportunities. She was CEO of Dimension Therapeutics, a gene therapy company focused on developing novel treatments for rare diseases. She is Chair of the Court at the London School of Hygiene and Tropical Medicine and member of the Science Advisory Board at the FDA.
Annalisa holds a degree in Medicine, specialised in Cardiovascular Medicine, and served as a Medical Officer in the British Royal Navy.LinkedIn
Dr Laila Samady-Mustad, Partnership Advisor
Laila is a research scientist, strategic advisor, and entrepreneur with 20 years’ experience in the pharmaceutical, medical, and biotechnology industry in the UK, US, and France. Her expertise is in medical affairs, partnership, business development, and capital raising strategies. She is Chair of the Board of Advisors and Chief Scientific Officer at Vigilent Labs (digital health), Vice President at Covanos (med tech), Vice President at G3 Therapeutics (biotech), and has held several senior partnership roles at Boehringer Ingelheim.
Laila holds a PhD from University College London and her work led to a spin out company, BioVex, which was acquired by Amgen for $1Bn.LinkedIn